Oncology clinical trials

Explore recruiting oncology clinical trials.

Recruiting oncology studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oncology trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase IB/II, 2-Stage, Open-label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab (MEDI4736) + Paclitaxel and Durvalumab (MEDI4736) in Combination With Novel Oncology Therapies With or Without Paclitaxel for First-line Metastatic Triple Negative Breast Cancer (BEGONIA)

Poland

Phase I and Phase II (Integrated)- Other EU CTIS Study details

EXUROC Bladder Target - A phase Ib/ll study to determine the safety, tolerability, and efficacy of LP-184 treatment in patients with advanced/metastatic urothelial carcinoma

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 1 Study Evaluating the Safety, Tolerability, and Efficacy of BL-B01D1 in Subjects with Metastatic or Unresectable Non-Small Cell Lung Cancer and Other Solid Tumors

France, Spain, Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

TEMPLE - Thiopurine Enhanced Mutations for PD-1/​Ligand-1 Efficacy

Denmark

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

zAvatar test-guided therapeutic decision vs standard of care, in relapsed ovarian cancer and in metastatic breast cancer - A multicentric randomized clinical study with intervention

Portugal

Therapeutic use (Phase IV) EU CTIS Study details

A single arm phase II study evaluating intracranial efficacy of Sacituzumab govitecan (SG) with bevacizumab in patients with asymptomatic brain metastases from non-small cell lung cancer (NSCLC)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Oncology trials by city

Oncology in Toronto Oncology in Vancouver Oncology in Montreal Oncology in Calgary Oncology in Edmonton Oncology in Ottawa Oncology in Winnipeg Oncology in Quebec City Oncology in Hamilton Oncology in Kitchener Oncology in London Oncology in Halifax Oncology in New York Oncology in Los Angeles Oncology in Chicago Oncology in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease